Rocket Doctor, Inc.

Founded in 2020 and based in Santa Monica, US, Rocket Doctor Inc. , develops a digital healthcare platform that connects patients with healthcare professionals through telemedicine services, enhancing accessibility and convenience for users seeking medical advice. Rocket Doctor Inc. is focused on providing telemedicine solutions.

The company has successfully completed 2 funding deals, with the latest round being a Seed round of USD 3. 80 mn led by F7 Ventures, alongside investment from Emergent Medical Ventures. The firm was co-founded by Harry Cherniak and William Cherniak, with William serving as the CEO. RocketDoctor specializes in providing a comprehensive digital healthcare platform designed to facilitate telemedicine services.

Their core product offerings encompass a suite of tools that enable users to engage with healthcare professionals through video consultations, secure messaging, and electronic prescriptions. The platform addresses the growing need for accessible healthcare solutions by connecting patients with licensed medical practitioners, thereby streamlining the process of receiving medical advice and treatment. This service is particularly beneficial for individuals in remote areas or those with mobility challenges, offering a convenient alternative to traditional in-person visits. RocketDoctor targets various geographical markets, with notable penetration in urban centers across North America and Europe, catering to a diverse clientele that includes individual patients, healthcare providers, and corporate wellness programs.

RocketDoctor generates revenue primarily through a subscription-based model, offering tiered pricing plans tailored to individuals and businesses. These plans provide access to various features, including unlimited video consultations and personalized health assessments. Clients can subscribe on a monthly or annual basis, with the structure designed to incentivize long-term commitments through discounted rates for annual plans. The firm also engages in partnerships with healthcare institutions, allowing them to integrate RocketDoctor's platform into their existing services.

This business model supports direct-to-consumer transactions and fosters B2B relationships by enabling healthcare providers to offer telemedicine solutions to their patients, thereby augmenting their service offerings. The flagship service of RocketDoctor is its telehealth consultation feature, which has been positioned as a pivotal tool in the evolving landscape of digital healthcare. In February 2025, Treatment. com AI Inc.

agreed to fully acquire Rocket Doctor Inc. from Emergent Medical Ventures and F7 Ventures, with financial terms undisclosed. The acquisition is expected to facilitate the expansion of Rocket Doctor into new markets and enhance its product offerings, capitalizing on the recent Seed funding received.